[HTML][HTML] Therapeutic potential of autophagy-enhancing agents in Parkinson's disease

…, MC Chartier-Harlin, WDJ Van De Berg - Molecular …, 2017 - Springer
Converging evidence from genetic, pathological and experimental studies have
increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). …

Lysosomal dysfunction and α‐Synuclein aggregation in Parkinson's disease: diagnostic links

…, L Parnetti, T Beccari, WDJ van de Berg - Movement …, 2016 - Wiley Online Library
… Research of Wilma DJ van de Berg is funded by Stichting Parkinson Fonds, Internationale
Wilma DJ van de Berg reports the following disclosures: contract research and consultancy …

Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes

…, M Britschgi, H Stahlberg, WDJ Van de Berg… - Nature …, 2019 - nature.com
Parkinson’s disease, the most common age-related movement disorder, is a progressive
neurodegenerative disease with unclear etiology. Key neuropathological hallmarks are Lewy …

Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease

WDJ van de Berg, DH Hepp, AA Dijkstra… - Parkinsonism & related …, 2012 - Elsevier
Parkinson's disease (PD) is characterized by a gradual accumulation of neuropathology that
may begin many years before a clinical diagnosis can be made using currently accepted …

[HTML][HTML] Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease …

…, WDJ van de Berg, PJ Lucassen, AM van Dam - Acta neuropathologica …, 2014 - Springer
Next to α-synuclein deposition, microglial activation is a prominent pathological feature in the
substantia nigra (SN) of Parkinson’s disease (PD) patients. Little is known, however, about …

[HTML][HTML] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease

…, HW Berendse, WDJ Van De Berg… - Molecular …, 2016 - Springer
Background Despite decades of intensive research, to date, there is no accepted diagnosis
for Parkinson’s disease (PD) based on biochemical analysis of blood or CSF. However, …

Stage‐dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease

…, AJM Rozemuller, WDJ van de Berg - Movement …, 2014 - Wiley Online Library
To gain a better understanding of the significance of α‐synuclein pathological conditions
during disease progression in Parkinson's disease, we investigated whether 1) nigral neuronal …

[HTML][HTML] The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy

…, K Gerwert, M Britschgi, WDJ van de Berg - Acta …, 2021 - Springer
Various post-translationally modified (PTM) proteoforms of alpha-synuclein (aSyn)—including
C-terminally truncated (CTT) and Serine 129 phosphorylated (Ser129-p) aSyn—…

Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP‐δ

…, D Mastroeni, P Voorn, WDJ Van De Berg… - Aging cell, 2010 - Wiley Online Library
… Simone van den Berge was involved in the conception and design, collection and assembly
of … Wilma van de Berg was involved in provision of study material, collection of data, data …

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology

…, MT Ardah, E van Dam, WDJ van de Berg… - Neurobiology of …, 2015 - Elsevier
α-Synuclein (α-syn), a small protein that has the intrinsic propensity to aggregate, is implicated
in several neurodegenerative diseases including Parkinson’s disease (PD), dementia …